ArticlePublic health weekly report2026
Characteristics of Carbapenem-Resistant
Article in Public health weekly report, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Antimicrobial resistance is increasing worldwide. In particular, the rising incidence of infections caused by Carbapenem-resistant Methods: This analysis was based on CRE infection cases reported through the Korea Disease Control and Prevention Agency's integrated infectious disease surveillance system from 2020 to 2024. Results: In 2024, a total of 2,454 CRE infection cases were reported in the Chungcheong region. The proportion of individuals aged 70 years and older showed a yearly increasing trend, rising from 62.7% (459 cases) in 2020 to 69.4% (1,702 cases) in 2024. By type of healthcare institution, general hospitals accounted for the largest proportion of reported cases at 51.7% (1,269 cases), while long-term care hospitals accounted for 16.1% (394 cases), which were identified for the first time in 2024. Among Carbapenemase-producing CRE (CP-CRE) infections, Conclusions: Since CRE infections were designated as a nationally notifiable infectious disease in the Republic of Korea in 2017, the number of reported cases in the Chungcheong region has increased annually, and the proportion of CP-CRE infections has also risen. In particular, the initially reported cases in long-term care hospitals highlight the importance of infection prevention and control in these facilities. Active cooperation among medical institutions, local governments, and the central government is required to strengthen CRE infection surveillance and response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.